John E. Wagner
Impact in
- Hematology top 0.01%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Immunology top 0.2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Hematology 329
- Hematopoietic Stem Cell Transplantation 325
- Immunology 35
- Immune Cell Function and Interaction 18
- T-cell and B-cell Immunology 12
- Co-authors
- Todd E. DeFor (104 shared papers)Daniel Jordan Weisdorf (130 shared papers)Bruce R. Blazar (101 shared papers)Juliet N. Barker (42 shared papers)Claudio G. Brunstein (123 shared papers)Jeffrey S. Miller (79 shared papers)Margaret L. MacMillan (83 shared papers)Philip B. McGlave (29 shared papers)
- Journals
- Transplantation and Cellular Therapy (117 papers)Blood (102 papers)Bone Marrow Transplantation (19 papers)Transfusion (11 papers)Blood Advances (11 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
John E. Wagner
420 papers receiving 28.8k citations
John E. Wagner's Hit Papers
Peers
Comparison fields: 5 of 148
- Hematology 18.9k
- Immunology 4.3k
- Genetics 1.5k
- Oncology 1.8k
- Transplantation 167
Countries citing papers authored by John E. Wagner
This map shows the geographic impact of John E. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Wagner more than expected).
Fields of papers citing papers by John E. Wagner
This network shows the impact of papers produced by John E. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Wagner. The network helps show where John E. Wagner may publish in the future.
Co-authors
The 25 scholars most cited alongside John E. Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 430 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer Hit paper breakdown → | 2005 | 1585 |
| 2 | Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia Hit paper breakdown → | 2004 | 897 |
| 3 | Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics Hit paper breakdown → | 2010 | 892 |
| 4 | Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival Hit paper breakdown → | 2002 | 828 |
| 5 | Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors Hit paper breakdown → | 2001 | 736 |
| 6 | Graft-Versus-Host Disease in Children Who Have Received a Cord-Blood or Bone Marrow Transplant from an HLA-Identical Sibling Hit paper breakdown → | 2000 | 703 |
| 7 | Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy Hit paper breakdown → | 2004 | 699 |
| 8 | Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study Hit paper breakdown → | 2007 | 651 |
| 9 | Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis Hit paper breakdown → | 2010 | 477 |
| 10 | 1995 | 471 | |
| 11 | 2007 | 431 | |
| 12 | 1992 | 402 | |
| 13 | 2020 | 391 | |
| 14 | 2010 | 380 | |
| 15 | 2003 | 358 | |
| 16 | 2001 | 357 | |
| 17 | Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect Hit paper breakdown → | 2015 | 352 |
| 18 | 2002 | 344 | |
| 19 | 1997 | 336 | |
| 20 | First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation Hit paper breakdown → | 2018 | 336 |
About John E. Wagner
John E. Wagner is a scholar working on Hematology, Immunology, Genetics, Cell Biology and Genetics, having authored 430 papers that have together received 29.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (325 papers), Immune Cell Function and Interaction (18 papers), Blood disorders and treatments (13 papers), T-cell and B-cell Immunology (12 papers), Skin and Cellular Biology Research (11 papers), Lysosomal Storage Disorders Research (10 papers), DNA Repair Mechanisms (10 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Hematology (18.9k citations), Immunology (4.3k citations), Genetics (1.5k citations), Oncology (1.8k citations) and Transplantation (167 citations). John E. Wagner has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Todd E. DeFor, Daniel Jordan Weisdorf, Bruce R. Blazar, Juliet N. Barker, Claudio G. Brunstein, Jeffrey S. Miller, Margaret L. MacMillan, Philip B. McGlave, Stella M. Davies and Mary M. Horowitz. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Bone Marrow Transplantation, Transfusion and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.